RenovoRx (RNXT) Cash from Financing Activities (2024 - 2025)

RenovoRx (RNXT) has disclosed Cash from Financing Activities for 2 consecutive years, with $34000.0 as the latest value for Q2 2025.

  • Quarterly Cash from Financing Activities fell 99.65% to $34000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $10.8 million through Dec 2025, down 28.26% year-over-year, with the annual reading at $10.8 million for FY2025, 28.26% down from the prior year.
  • Cash from Financing Activities hit $34000.0 in Q2 2025 for RenovoRx, down from $10.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $10.8 million in Q1 2025 to a low of $15000.0 in Q3 2024.